Showing results (341-350 of 2,576) with videos related to
Sort By:
Pageof 258
Molecular Oncology|September 3, 2017
Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levelsLiJun Xu, XiaoDong Chen, MingJing Shen, et al.Molecular Oncology|September 8, 2017
A genetically inducible porcine model of intestinal cancerMorten M Callesen, Sigrid S Árnadóttir, Iben Lyskjaer, et al.Molecular Oncology|September 27, 2017
Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastasesNick Beije, Jean C Helmijr, Marjolein J A Weerts, et al.Molecular Oncology|June 18, 2016
Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgeryJérôme Alexandre Denis, Alexia Patroni, Erell Guillerm, et al.Molecular Oncology|September 8, 2020
Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastomaYan Su, Lijun Wang, Qian Zhao, et al.Molecular Oncology|November 6, 2020
Loss of STAT5A promotes glucose metabolism and tumor growth through miRNA-23a-AKT signaling in hepatocellular carcinomaYabo Jiang, Yongzhen Tao, Xiuping Zhang, et al.Molecular Oncology|November 6, 2020
BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTENRong Deng, Yanmin Guo, Lian Li, et al.Molecular Oncology|October 27, 2020
A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progressionRui Sun, Zhong Zheng, Li Wang, et al.Molecular Oncology|October 27, 2020
The KRAS/Lin28B axis maintains stemness of pancreatic cancer cells via the let-7i/TET3 pathwayYawen Liu, Dawei Wang, Meng Zhou, et al.Molecular Oncology|November 18, 2020
HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple-negative breast cancerXin Guo, Aman Wang, Wen Wang, et al.Pageof 258